https://www.selleckchem.com/products/fgf401.html
Clinical improvement with cat extract was significantly higher than with dog. An increase of 0.9 in ESPRINT-15 health-related quality of life in allergic rhinitis) was observed in 49.09% of patients, and 58.18% showed an increase of 0.5 in AQLQ(asthma quality of life questionnaire), at month 6, both differences indicating the minimal important difference. A significant increase was observed in specific IgG and IgE to different allergens at 3 and/or 6 months. Ultrarush SCIT with cat and dog extracts has substantial clinical value
Like
Comment
Share
